Scientist II/Senior Scientist, Biomarker Research
Immediate opening is available for a passionate scientist to join our Translational Sciences team as a Senior Scientist Biomarker Researcher. This individual will join a dynamic and growing multidisciplinary team focused on discovery and advancement of new drug candidates and disease biomarkers in fibrosis, oncology, and muscular dystrophy.
The successful candidate will report to a Principal Scientist in the Translational Sciences group and be responsible for the discovery, validation and application of biomarkers and novel translational tools to support early clinical PD and efficacy evaluations. This will include working closely with discovery, preclinical and clinical teams. Successful candidate will apply cutting edge proteomic, genomic, and biochemical assay technologies to disease biomarker discovery in fibrosis, oncology and muscular dystrophy working with clinical samples, precision cut tissue slices and in vivo animal models of disease. A strong background in biomarker discovery, bioinformatics, physiology is preferred.
- Advance ongoing biomarker discovery efforts in IPF, PSC, oncology, and muscular dystrophy
- Develop a PK/PD and translational medicine plans to advance lead candidates to clinic
- Coordinate activities of consultants and contract labs
- Develop and meet team timelines
- Evaluate new targets and in-licensing opportunities
- PhD in Biology, Biochemistry or related field.
- Minimum 3 years industry experience in biomarker or translational medicine research.
- Strong foundational knowledge in biological pathways related to fibrotic and/or inflammatory disease, oncology, or muscular dystrophy preferred.
- Experience in bioinformatics and statistical analysis of large datasets.
- Desire to work in a fast paced, experienced research and development environment managing internal and external collaborations
- Candidate should exhibit strong, positive attitude for teamwork and learning.
- Ability to thrive in a culture of respect, accountability, transparency, and collaboration.